Privia Health Group Target Price

Analysts' average 12-month price target for Privia Health Group is $28.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.07

Average Target Price

$28.00

32.9% upside

2 analysts in the last 4 months

High: $32 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Canaccord Genuity	$32	51.9% upside
2026-05-26	BarclaysAndrew Mok	$24	13.9% upside
2026-04-08	Evercore ISI	$26	23.4% upside
2026-02-26	JefferiesJack Slevin	$32	51.9% upside
2026-02-26	Piper SandlerJessica Tassan	$36	70.9% upside
2026-01-09	RBC Capital	$31	47.1% upside
2026-01-06	Wolfe Research	$31	47.1% upside
2025-11-12	Canaccord Genuity	$34	61.4% upside
2025-10-09	Barclays	$22	4.4% upside
2025-08-29	JMP Securities	$30	42.4% upside
2025-04-15	Robert W. BairdMichael Ha	$26	23.4% upside
2025-02-28	JMP Securities	$29	37.6% upside
2025-02-28	Piper Sandler	$40	89.8% upside
2025-02-28	Canaccord Genuity	$30	42.4% upside
2025-01-10	NeedhamMatthew Shea	$25	18.7% upside
2024-08-26	Robert W. BairdMichael Ha	$24	13.9% upside
2024-08-08	Evercore ISIElizabeth Anderson	$22	4.4% upside
2024-05-20	BarclaysAndrew Mok	$19	9.8% downside
2024-05-15	Truist FinancialJailendra Singh	$24	13.9% upside
2022-12-08	UBS	$30	42.4% upside
2022-11-17	Canaccord GenuityCanaccord Canaccord	$43	104.1% upside
2022-11-11	Leerink Partners	$39	85.1% upside
2022-08-25	Canaccord Genuity	$50	137.3% upside
2022-08-12	Truist Financial	$48	127.8% upside
2022-08-12	Credit Suisse	$41	94.6% upside
2022-08-12	Cowen & Co.	$44	108.8% upside
2022-08-12	GuggenheimSandy Draper	$51	142.1% upside
2022-08-12	Leerink Partners	$46	118.3% upside
2022-07-25	Truist FinancialDavid MacDonald	$40	89.8% upside
2022-05-13	Canaccord Genuity	$29	37.6% upside
2022-04-28	BTIG	$35	66.1% upside

Privia Health Group (PRVA) FAQ

Privia Health Group (PRVA) currently reports a target price of $28. Use the charts on this page to explore Privia Health Group's target price history and peer comparisons.

Analysts' average 12-month price target for Privia Health Group is $28, about 32.9% upside from the current share price of $21.07. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $28, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Privia Health Group, and consider following PRVA for alerts when major investors trade the stock.

Privia Health Group is classified in the Healthcare sector. On target price, it currently shows $28. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRVA with unrelated industries.